AVAI BIO, INC. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that AVAI BIO, INC. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Net Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2026 | Dec 31, 2025 | ($553.7K) | Feb 12, 2026 |
| Q2 | 2026 | Sep 30, 2025 | ($453.0K) | Nov 14, 2025 |
| Q3 | 2026 | Sep 30, 2025 | ($453.0K) | Feb 12, 2026 |
| Q3 | 2026 | Jun 30, 2025 | ($487.6K) | Feb 12, 2026 |
| Q1 | 2026 | Jun 30, 2025 | ($487.6K) | Aug 12, 2025 |
| Q2 | 2026 | Jun 30, 2025 | ($487.6K) | Nov 14, 2025 |
| Q3 | 2026 | Dec 31, 2024 | ($452.3K) | Feb 12, 2026 |
| Q2 | 2026 | Sep 30, 2024 | ($623.0K) | Nov 14, 2025 |
| Q3 | 2026 | Sep 30, 2024 | ($625.0K) | Feb 12, 2026 |
| Q1 | 2026 | Jun 30, 2024 | ($528.8K) | Aug 12, 2025 |
| Q3 | 2026 | Jun 30, 2024 | ($528.8K) | Feb 12, 2026 |
| Q2 | 2026 | Jun 30, 2024 | ($528.8K) | Nov 14, 2025 |
| Q3 | 2025 | Dec 31, 2023 | ($1.01M) | Feb 7, 2025 |
| Q3 | 2025 | Sep 30, 2023 | ($399.6K) | Feb 7, 2025 |
| Q2 | 2025 | Sep 30, 2023 | ($399.6K) | Jan 21, 2025 |
| Q2 | 2025 | Jun 30, 2023 | ($411.5K) | Jan 21, 2025 |
| Q1 | 2025 | Jun 30, 2023 | ($411.5K) | Jan 21, 2025 |
| Q3 | 2025 | Jun 30, 2023 | ($411.5K) | Feb 7, 2025 |
| Q3 | 2024 | Dec 31, 2022 | ($110.5K) | Feb 14, 2024 |
| Q3 | 2024 | Sep 30, 2022 | ($83.8K) | Feb 14, 2024 |
Operating Income — By Quarter
| Quarter | Fiscal Year | Period End | Value | Filed |
|---|---|---|---|---|
| Q3 | 2026 | Dec 31, 2025 | ($553.7K) | Feb 12, 2026 |
| Q2 | 2026 | Sep 30, 2025 | ($453.0K) | Nov 14, 2025 |
| Q1 | 2026 | Jun 30, 2025 | ($487.6K) | Aug 12, 2025 |
| Q3 | 2026 | Dec 31, 2024 | $452.3K | Feb 12, 2026 |
| Q2 | 2026 | Sep 30, 2024 | $623.0K | Nov 14, 2025 |
| Q1 | 2026 | Jun 30, 2024 | ($528.8K) | Aug 12, 2025 |
| Q3 | 2024 | Dec 31, 2023 | $1.01M | Feb 14, 2024 |
| Q2 | 2024 | Sep 30, 2023 | $399.6K | Nov 17, 2023 |
| Q1 | 2023 | Jun 30, 2023 | $411.5K | Aug 16, 2023 |
| Q3 | 2024 | Dec 31, 2022 | $110.5K | Feb 14, 2024 |
| Q2 | 2024 | Sep 30, 2022 | $83.8K | Nov 17, 2023 |
| Q1 | 2023 | Jun 30, 2022 | $29.8K | Aug 16, 2023 |
| Q3 | 2023 | Dec 31, 2021 | $349.3K | Feb 14, 2023 |
| Q2 | 2023 | Sep 30, 2021 | $166.3K | Nov 10, 2022 |
| Q1 | 2023 | Jun 30, 2021 | ($396.3K) | Aug 19, 2022 |
| Q3 | 2022 | Dec 31, 2020 | $417.2K | Feb 14, 2022 |
| Q2 | 2022 | Sep 30, 2020 | ($50.5K) | Nov 15, 2021 |
| Q1 | 2021 | Jun 30, 2020 | $48.7K | Aug 23, 2021 |
| Q3 | 2020 | Dec 31, 2019 | ($83.0K) | Feb 4, 2020 |
| Q3 | 2020 | Dec 31, 2018 | ($51.5K) | Feb 4, 2020 |